A review of epidemiologic studies of workers exposed to vinyl chloride (VC) was conducted. Some of these studies comprised small cohorts and thus were insensitive in the evaluation of carcinogenic response for sites that do not demonstrate a high relative risk. Other larger studies used methodology and design that precluded an interpretation of the results. Such limitations were acknowledged by some authors.
In 1930, shortly after vinyl chloride (VC) was introduced into commerce, VC toxicity was reported in experimental animals (1) . Over the next five decades, study throughout the world indicated that employment in the VC industry was associated with a wide range of toxicity in humans. This toxicity has included nonmalignant pathologic effects or symptoms, involving (but not limited to) the bones, liver, central nervous system (CNS), lungs, and blood (2) .
Between 1970 and 1974, experimental bioassay demonstrated VC-induced cancer in multiple organs including the liver, brain, lungs and lymphatic system (3, 4) . This carcinogenic response has been October 1981 observed in several species, given a wide range of doses, by various routes of administration.
Between 1973 and 1977 , several epidemiologic studies were undertaken to assess the site-specific cancer risk among workers exposed to VC. For this presentation, findings of these studies will be limited to an assessment of cancer of four organs or organ systems in humans. These same sites are known to be associated with nonmalignant VCrelated disease or symptoms in humans and cancer in experimental animals.
Liver Cancer in Humans Table 1 shows a summation of data from the epidemiologic studies as related to liver cancer. Some authors did not present site-specific analyses for liver cancer deaths. Therefore, the most specific information available is presented.
Waxweiler et al. (5) conducted a cohort study of workers who had been exposed to VC in the U.S. Fox and Collier (7) studied U.K. workers exposed to VC. In eight factories studied, they observed a total of four liver cancer deaths as compared to 1.64 expected. Three of these deaths occurred in factory 2, where only 0.13 would have been expected (p < 0.01). The authors stated that it was difficult to identify angiosarcoma of the liver from death certificates (the usual method of identification), since some of these deaths were classified as primary, some as secondary liver cancer, and others were not certified as cancer deaths at all.
The results from the Fox and Collier study probably represent an underestimate of the observed risk of death from cancer for the following reasons: (1) 75% of the study cohort was employed for less than ten years; (2) (12) reported the mortality of a cohort of workers from 37 U.S. industrial facilities. This study included data for the facilities studied by Tabershaw and Gaffey (9). Data were not analyzed separately for liver cancer. However, the category of death from cancer of the digestive organs, which includes liver cancer deaths, indicates a deficit of mortality. As shown in Table 1 , even for those individuals who had achieved 20 or more years of latency, the SMR was only 70. It is somewhat unusual to observe such a deficit of mortality among workers who had achieved such a long latency period.
Brain Cancer in Humans
Brain cancer also has been associated with exposure to VC. A summary of the results of mortality studies is shown in Tabershaw and Gaffey (9) categorized brain cancer with "other and unspecified causes of cancer death;" therefore, it is not possible to determine the actual brain cancer risk identified in this study. Since the Tabershaw and Gaffey study (9) was a subset of the EEH study (12) , the latter study was used to estimate the expected number of brain cancer deaths in the former study under the assumption that the age distributions were similar. The proportion of expected brain cancer deaths from "other and unspecified cancer deaths" in the EEH study (12) was then applied to the expected from this same category in the Tabershaw and 91 Gaffey study (9) . As a result, 2.4 brain cancer deaths were estimated to have been expected and compared to six observed in the study. This difference is significant. Buffier et al. (10) did not identify any deaths from brain cancer in their small cohort. Ott et al. (11) did not analyze their data separately for brain cancer, but rather included brain cancer deaths with cancer deaths from "all sites other than digestive and respiratory." Therefore, using an analytical technique similar to that described above, the proportion of expected brain cancer deaths among "all sites other than digestive and respiratory" from the EEH study (12) was applied to the expected in the study by Ott et al. (11) . As shown in Table 2 , there was a resultant estimated 0.7 brain cancer deaths expected as compared to two observed. The excess risk is estimated to be about threefold. The EEH study (12) also demonstrates a significant excess brain cancer among workers occupationally exposed to VC. In summary, the data for brain cancer appear to be more consistent between studies than the data for liver cancer, although the magnitude of the excessive risk is not as great for brain cancer. 92
Lung Cancer in Humans
As shown in Table 3 With the exception of the study by Fox and Collier (7), the remaining studies show excess risks of lung cancer ranging from 7 to 200%. However, the reservation expressed by Fox and Collier (7), as mentioned earlier, about the short period of followup limits the interpretation of their study. This concern is supported by the observation that the SMR for total mortality was only 75, 75% of what would be expected on the basis of comparison to the standard population.
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As shown in Table 3 Table 4 summarizes data on cancer of the lymphatic and hematopoietic systems among workers exposed to VC. The relative risks for various studies ranged from 1.0 to 2.2, and none of the results demonstrated a significant excess. Although somewhat suggestive, the data need to be further analyzed by latency period and exposure levels combined. Analysis of data separately for lymphatic cancers and leukemia might also lead to meaningful observations.
Summary
In summary, epidemiologic evidence demonstrates that the carcinogenic effects of VC in humans extend beyond the liver. The brain and lung should also be considered target organs. Some studies indicate that the lymphatic and hematopoietic systems are also involved. These observations in humans are supported by studies demonstrating the induction of cancer of these same sites in experimental animals.
